SHANXI ZHENDONG PHARMACEUTICAL CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.5 CNY | 0.00% |
|
+8.43% | -33.33% |
| Sales 2022 | 3.73B 515M | Sales 2023 | 3.63B 500M | Capitalization | 6.94B 957M |
|---|---|---|---|---|---|
| Net income 2022 | -51M -7.04M | Net income 2023 | -44M -6.07M | EV / Sales 2022 | 1.32 x |
| Net cash position 2022 | 2.72B 375M | Net cash position 2023 | 2.25B 310M | EV / Sales 2023 | 1.29 x |
| P/E ratio 2022 |
-149
x | P/E ratio 2023 |
-158
x | Employees | 3,693 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 15.09% |
More Fundamentals
* Assessed data
More news
| 1 week | +8.43% | ||
| Current month | -6.25% | ||
| 1 month | -8.35% | ||
| 3 months | -13.46% | ||
| 6 months | -23.60% | ||
| Current year | -33.33% |
1 week
4.04
4.59
1 month
3.954.94
Current year
3.627.00
1 year
3.628.47
3 years
3.6215.66
5 years
3.6215.66
10 years
3.5015.66
| Managers | Title | Age | Since |
|---|---|---|---|
Chang Lu Liu
DFI | Director of Finance/CFO | 38 | 12-11-30 |
Lian Min Yang
PSD | President | 61 | 21-12-01 |
An Ping Li
CHM | Chairman | 62 | 00-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
An Ping Li
CHM | Chairman | 62 | 00-12-31 |
Zhi Min Wang
BRD | Director/Board Member | 59 | 08-12-09 |
Ren Hu Li
CHM | Chairman | 61 | 08-12-09 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 4.5 | 0.00% | 26 140 730 |
| 24-04-25 | 4.5 | +1.35% | 26,921,130 |
| 24-04-24 | 4.44 | +2.30% | 29,517,600 |
| 24-04-23 | 4.34 | +4.33% | 34,270,990 |
| 24-04-22 | 4.16 | +1.22% | 14,812,310 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Shanxi Zhendong Pharmaceutical Co.,Ltd is a China-based company principally engaged in the research, development, production and sale of Chinese patent drugs, chemical raw materials and preparations. The Company's main products include anti-tumor series, cardiovascular and cerebrovascular series, anti-infection series, digestive system series, vitamin nutrition series, respiratory system series, antipyretic analgesic series and nervous system series. The Company is also involved in the cultivation of medicinal herbs, as well as the wholesale and retail of pharmaceutical products. The Company distributes its products in domestic market, with North China market as its main market.
Sector
Pharmaceuticals
Calendar
2024-05-16
- Annual General Meeting
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -33.33% | 638M | |
| +26.16% | 653B | |
| +27.00% | 556B | |
| -6.57% | 354B | |
| +20.58% | 331B | |
| +3.23% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -5.88% | 144B |
- Stock Market
- Equities
- 300158 Stock
